Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical Trial.
Annals of Emergency Medicine · 2016-10-10 · Randomised trial
Abstract
STUDY OBJECTIVE: We aim to determine the most efficacious of 3 common medication regimens for the sedation of acutely agitated emergency department (ED) patients. METHODS: We undertook a randomized, controlled, double-blind, triple-dummy, clinical trial in 2 metropolitan EDs between October 2014 and August 2015. Patients aged 18 to 65 years and requiring intravenous medication sedation for acute agitation were enrolled and randomized to an intravenous bolus of midazolam 5 mg-droperidol 5 mg, droperidol 10 mg, or olanzapine 10 mg. Two additional doses were administered, if required: midazolam 5 mg, droperidol 5 mg, or olanzapine 5 mg. The primary outcome was the proportion of patients adequately sedated at 10 minutes. RESULTS: Three hundred forty-nine patients were randomized to the 3 groups. Baseline characteristics were similar across the groups. Ten minutes after the first dose, significantly more patients in the midazolam-droperidol group were adequately sedated compared with the droperidol and olanzapine groups: differences in proportions 25.0% (95% confidence interval [CI] 12.0% to 38.1%) and 25.4% (95% CI 12.7% to 38.3%), respectively. For times to sedation, the differences in medians between the midazolam-droperidol group and the droperidol and olanzapine groups were 6 (95% CI 3 to 8) and 6 (95% CI 3 to 7) minutes, respectively. Patients in the midazolam-droperidol group required fewer additional doses or alternative drugs to achieve adequate sedation. The 3 groups' adverse event rates and lengths of stay did not differ. CONCLUSION: Midazolam-droperidol combination therapy is superior, in the doses studied, to either droperidol or olanzapine monotherapy for intravenous sedation of the acutely agitated ED patient.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antipsychotics · Midazolam · Sedatives & anxiolytics
Related articles
- Efficacy and safety of intramuscular and intravenous midazolam for acute agitation in emergency settings: a systematic review. (Int Clin Psychopharmacol, 2026)
- Prehospital management of acute behavioural disturbance: managing severe agitation in the prehospital setting - a systematic literature review. (Emerg Med J, 2026)
- Comparative Safety of Medications for Severe Agitation: A Geriatric Emergency Department Guidelines 2.0 Systematic Review. (J Am Geriatr Soc, 2025)
- "Pharmacological management of acute agitation in psychiatric patients: an umbrella review". (BMC Psychiatry, 2025)
- Rapid tranquilization of the agitated patient in the emergency department: A systematic review and network meta-analysis. (Am J Emerg Med, 2022)
- The effectiveness of chemical restraint in managing acute agitation and aggression: A systematic review of randomized controlled trials. (Int J Ment Health Nurs, 2020)